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Coumarins  are  phenolic  compounds  and  have  various  biological  properties,  including  antioxidant  activ-
ity.  The  isocoumarin  paepalantine,  isolated  from  of  Paepalanthus  bromelioides  Silveira,  Eriocaulaceae,
exhibits  a wide  range  of biological  activities,  including  antimicrobial,  anti-inﬂammatory,  antioxidant
and  cytotoxic  properties.  Studies  on paepalantine  often  use  dimethylsulfoxide  as  a  solvent.  However  the
dimethylsulfoxide  interferes  with  antimicrobial,  cytotoxic  and  antioxidant  assays.  Thus, this  study  aims
to evaluate  alternative  solvents  for  paepalantine  and evaluate  their  potential  to  interfere  with  antioxidant
assays  (ABTS•+, O2•−, HOCl).  Of the  selected  solvents,  propylene  glycol  had  good  solubility  and  remained
stable  throughout  the study  period.  The  results  suggested  that  there  is no  interference  from  propylenereformulation
glycol  in  antioxidant  assays,  while  dimethylsulfoxide  signiﬁcantly  interfered  with  the  HOCl  assay.  The
antioxidant  assays  showed  that  paepalantine  demonstrated  similar  or even  better  antioxidant  activity
than Trolox.  Thus,  propylene  glycol  may  be  the  solvent  of  choice  for paepalantine,  a compound  that  has
signiﬁcant  biological  potential.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Natural products have always contributed to the discovery and
evelopment of novel molecules. An analysis of all substances
pproved by the FDA as new molecular entities demonstrates that
ore than one-third of the total number of substances corresponds
o natural products and their semi-synthetic derivatives (Patridge
t al., 2015). Among natural products, plants are a rich source
f therapeutic agents and bases for synthetic drugs. Despite the
dvances in organic synthesis, currently 25% of prescribed drugs
orldwide are still derived from plant sources, thus showing that
lant species are still an important source of novel drugs for dis-
ases that continue to lack treatment option (Newman and Cragg,
012; Rates, 2001).
The Eriocaulaceae family distributed in the mountainous
egions of South America, especially in the rocky savannas of Brazil,
∗ Corresponding author.
E-mail: rodrigo.kitagawa@ufes.br (R.R. Kitagawa).
http://dx.doi.org/10.1016/j.bjp.2015.07.008
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoracontains about 1400 species belonging to eleven genera (Alvarado
et al., 2013). Paepalanthus, with about 500 species, is one of its
principal genera commonly found in the States of Bahia and Minas
Gerais, Brazil. A number of studies have demonstrated that almost
all species of Paepalanthus subgenus Platycaulon possess ﬂavonoids,
naphthoquinones, caffeic acid, and naphthopyranone derivatives,
including paepalantine (1) and 8,8-paepalantine dimer isolated
from P. bromelioides (Vilegas et al., 1990; Coelho et al., 2000), plani-
folin isolated from P. planifolius (Santos and Vilegas, 2001; Varanda
et al., 2006), and 5-methoxy-3,4-dehydroxanthomegnin isolated
from P. latipes Silveira (Kitagawa et al., 2004).
Currently, some of these compounds are of notable pharma-
cological interest owing to their proven biological activity; for
example, it has been reported that the isocoumarin paepalantine
(1), present in different extracts of P. bromelioides and P. vel-
lozioides, exhibits a wide range of biological activities, including
antimicrobial (Devienne and Raddi, 2002; Devienne et al., 2005),
anti-inﬂammatory (Di Stasi et al., 2004), antioxidant (Kitagawa
et al., 2003; Devienne et al., 2007), cytotoxic (Varanda et al.,
1997; Devienne et al., 2002), genotoxic (Tavares et al., 1999) and
 Ltda. All rights reserved.
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utagenic activities (Varanda et al., 2004).
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Despite several studies reporting biological activities of
aepalantine (1), the data regarding the behaviour of paepalantine
n different solvents are limited. Studies performed with paepalan-
ine often use dimethylsulfoxide (DMSO) as the solvent. However,
his solvent is toxic to humans and experimental animal mod-
ls (White et al., 2013; Galvão et al., 2014), induces apoptosis
nd disruption of the membrane in cell culture models (Ménorval
t al., 2012; Yuan et al., 2014), interferes with antioxidant activity
Kabeya et al., 2013), and exerts multiple harmful systemic effects,
hus making it a controversial molecule for research (Santos et al.,
003; Qi et al., 2008; Galvão et al., 2014).
The evaluation of its bacteriostatic potential in vitro showed that
MSO solution 30% is highly bactericidal towards a wide range
f microorganisms (Jacob and Herschler, 1986). Thereby, DMSO in
olution form interferes with the tests evaluating the bactericidal
otential of natural products.
An important step in the development of a novel drug is the
valuation of its physicochemical characteristics and possible inter-
ctions with adjuvants that may  be used for its development.
hemical interactions of the drug with potential solvents can alter
ts solubility, bioavailability, validity, and ultimately mask the
ssessed biological activity (Wang et al., 2006). Additionally, this
tep is important for determining the non-toxic adjuvants that
an be used in animals and humans, while analytical methods
or quality control of the molecule are investigated and evaluated
Gowthamarajan and Singh, 2010).
Taken together, the objective of the current study was  to evalu-
te solvents that solubilise paepalantine, without any interference
ith its analysis and which have minimal toxicity in case of in vivo
ests.
aterial and methods
lant material
Paepalanthus bromelioides Silveira, Eriocaulaceae, was  collected
n Serra do Cipo, State Minas Gerais, Brazil, and identiﬁed by Dr.
aulo Takeo Sano associated with the Institute of Biosciences, Uni-
ersity of São Paulo. The voucher specimen (CFSC, 13839) was
eposited at the Herbarium in the Department of Botany, Institute
f Biosciences, University of São Paulo, Brazil.
hemicals
Dimethyl sulfoxide (DMSO), nitrotetrazolium blue chloride
NBT), 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), 2,2′-azino-
is(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), nicotinamide
denine dinucleotide (NADH), potassium persulfate, phenazine
ethosulfate (PMS), sodium borohydride, Trolox, and EDTA were
urchased from Sigma Chemical Co. (St. Louis, MO,  USA). Propylene
lycol was purchased from Neon Comercial Ltda. (São Paulo, SP, BR).
aepalantine was obtained according to the procedure previously
eported by Vilegas et al. (1990), and the stock solution was  pre-
ared at 10 mg/ml  in different solvents including DMSO. Maximum
bsorbance of paepalantine was observed at 265 nm. Farmacognosia 25 (2015) 395–400
Solubility test
The solvents selected had values close to the dielectric con-
stant of DMSO. Thus, propylene glycol, isopropanol, and glycerin
were selected and evaluated in context of the dissolution proﬁle
of paepalantine taking the following parameters into consider-
ation: concentration (10, 20 and 40 mg/ml), temperature (ambient
or 37 ◦C), pH (5.0 and 7.5) and addition of surfactant (0.02% Tween
80 or Tween 20). The evaluation consisted of determination of
homogeneity and transparency of the solution by visual analysis.
The presence of paepalantine crystals was  evaluated by optical
microscopy (Olympus AX70, Olympus optical Co., Tokyo, Japan)
using the appropriate software (Leica IM 1000 Software, Wetzlar,
Germany). The microscope was  equipped with a digital camera
(Axiocam ERc 5s, Zeiss, Jena, Germany). Based on ﬁndings from
the solubility tests, appropriate solvents were selected for future
experiments.
UV spectrophotometry
Spectroscopy measurements were carried out by a UV/VIS spec-
trophotometer NANO DROP 2000 Thermo Scientiﬁc (Wilmington,
USA). UV spectra at 200–800 nm were recorded for peak identiﬁ-
cation.
Validation of spectrophotometric analytical method
The items validation followed RE N◦899 of May  29, 2003 of the
Guide of Validation of analytical and bioanalytical methods from
National Agency for Sanitary Vigilance (Anvisa, 2003).
Selectivity
The selectivity was determined from the comparison of the UV
spectra of the following solutions: propylene glycol, DMSO, and
paepalantine solutions in propylene glycol or DMSO.
Linearity
Paepalantine (1) (10 mg/ml) was  dissolved in 1 ml  of solvent
(propylene glycol or DMSO). Aliquots of this solution were diluted
in different concentrations: 0.1, 0.25, 0.37, 0.5, and 0.75 mg/ml, pre-
pared in triplicate. The amount of paepalantine was  determined by
means of UV spectrophotometry. Calibration curves of concentra-
tion versus area were plotted, and the obtained data were subjected
to regression analysis using the least-squares method.
Precision
Repeatability of spectrophotometric method was tested by ana-
lyzing concentrations levels of 0.1, 0.5 and, 0.75 mg/ml on three
different days (n = 10). Paepalantine concentration was  determined
and the Relative Standard Deviation (RSD) was calculated.
Stability of solutions
Paepalantine (0.1, 0.25, 0.37, 0.5, and 0.75 mg/ml) stability in
propylene glycol or in DMSO was determined by spectrophotome-
ter. Post-preparation of the solutions analyses were carried out on
days 1, 2, 3, 7, 14, 21, and 28 (n = 10) for every solution. Absorbance
data were graphically represented as a function of time.
Antioxidant assaysDifferent strengths of the solvents were evaluated in vary-
ing concentrations of 0.31, 0.62, 1.25, 2.5, 5, 10% v/v. The tested
paepalantine concentrations were 3.125, 6.25, 12.5, 25, 50, and
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00 g/ml. Trolox® was used as the standard antioxidant sub-
tance. The assays were performed in triplicate and repeated at
east three times.
The results are expressed as percent inhibition (%)  and 50%
ffective concentration (EC50). The equation used for calculating
he percent inhibition was as follows: %  = (A0 − A/A0)*100, where
0 is the absorbance of the test solution without a sample (control),
nd A is the absorbance observed with sample.
BTS•+ assay
The antioxidant activity against ABTS•+ was  determined using
 modiﬁed method originally described by Re et al. (1999). Ini-
ially, an aqueous mixture of ABTS (7 mM)  and potassium persulfate
2.45 mM)  was incubated at room temperature in the dark for 16 h.
he solution formed from ABTS•+ exposure was  diluted in ethanol
o generate an absorbance of 0.7 at 734 nm.  In a 96-well microplate,
00 l of ABTS•+ and 3 l of the samples at different concentrations
ere added. After 5 min, spectrophotometric measurements were
arried at 734 nm using iMark® Microplate Absorbance Reader,
rom Bio Rad Laboratories (Washington, U.S.A.).
BT assay
A modiﬁed superoxide radical test (O2•−) was performed based
n a method previously described by Suzumura et al. (1999).
n a 96-well microplate, varying concentrations of paepalantine,
henazine methosulfate (PMS) (0.5 mM),  nitrotetrazolium blue
hloride (NBT) (0.045 mM)  and phosphate buffer, pH 7.4, were
dded. The mixture was incubated for 2 min, followed by addi-
ion of 0.125 mM nicotinamide adenine dinucleotide (NADH). After
ncubation for 10 min  at room temperature, spectrophotometric
easurements were carried out at 560 nm.
eaction with hypochlorous acid (HOCl)
HOCl reactions were studied using a previously described
ethod by Ching et al. (1994), which was based on the oxidation
f 5-thio-2-nitrobenzoic acid (TNB). TNB was obtained by reducing
 1 mM solution of 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) in a
0 mM KH2PO4–KOH buffer (pH 6.6), containing 5 mM EDTA, and
0 mM sodium borohydride. In order to perform the assay, 25 mM
OCl was incubated with 50 mM TNB for 5 min  in the presence
r absence of paepalantine in a ﬁnal volume of 200 l. The ability
f paepalantine to scavenge HOCl was determined by measuring
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Fig. 1. Paepalantine absorption Farmacognosia 25 (2015) 395–400 397
the oxidation of TNB to DTNB at 412 nm,  upon pre-incubating of
paepalantine with HOCl, followed by addition of TNB.
Statistical analysis
The parameters were expressed as mean ± standard deviation.
Data were analysed using analysis of variance (ANOVA) and linear
regression analysis. Differences between groups were considered
signiﬁcant at p < 0.05.
Results and discussion
Preformulation studies assist scientists in screening lead can-
didates based on their physicochemical and biopharmaceutical
properties. Preformulation information (permeability, solubility,
and stability) is useful for selection of new chemical entities for
preclinical efﬁcacy/toxicity studies, which is a major section under
investigational new drug applications (Bharate and Vishwakarma,
2013).
In this context, the present study evaluated the solubility of
paepalantine in solvents other than DMSO, and the solvent’s poten-
tial to interfere with antioxidant assays. According to results from
the solubility test, paepalantine was soluble only in propylene gly-
col at 10 mg/ml, pH 7.5, with complete dissolution (no crystals were
observed) as conﬁrmed by optical microscopy analysis. Further, the
use of surfactants was not favourable to solubilisation of paepalan-
tine in propylene glycol and other selected solvents.
After the analysis of spectra of pure solvents and paepalan-
tine’s solutions, the analytical wavelength of choice was  at 391 nm
(Fig. 1).
Linear correlation was  found for both propylene glycol and
DMSO solutions containing paepalantine. The regression analysis
data are shown in Fig. 2. The regression coefﬁcient (R2) obtained
was higher than 0.98 which attests to the linearity of the method.
The repeatability of spectrophotometric method for the
paepalantine’s solutions (propylene glycol and DMSO) resulted in
RSD values below 5% indicating the precision of the method.
The stability of paepalantine in propylene glycol and DMSO was
assessed by spectrophotometric analysis in different concentra-
tions during 28 days (Fig. 3). Paepalantine’s solution in DMSO was
considered stable during the period of storage, while paepalatine’s
solution in propylene glycol showed a concentration reduction
(p < 0.05).
 (0.25 µg/ml)
lene glycol (0.25 µg/ml)
0 450
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500 550 600
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Table 1
Effective concentration (EC50) of paepalantine dissolved in propylene glycol and
DMSO and Trolox in ABTS•+ assay.
Compound EC50 (g/ml)
Paepalantine in propylene glycol 2.42 ± 0.5
glycol can be an alternative to the use of DMSO which shows inter-ropylene glycol (R2 = 0.99; a = −0.20; b = 1.33) and Paepalantine in DMSO (R2 = 0.98;
 = −0.17; b = 1.58). All absorbances were measured in triplicate.
Despite DMSO, being widely used as a universal solvent for nat-
ral products especially plant-derived products, previous studies
ave reported interference from this solvent owing to its toxic
ffects on various cell types, microorganisms, and animal mod-
ls. Hence, it has been replaced with other suitable solvents for
n in vivo experiments (Basch and Gadebusch, 1968; Vogin et al.,
970; Qi et al., 2008; Hanslick et al., 2009; Ménorval et al., 2012;
hite et al., 2013; Yuan et al., 2014). Propylene glycol is a fre-
uently co-administered solvent in formulations used in preclinical
nd clinical studies. This solvent is generally nontoxic and noncar-
inogenic, and commonly used solvent for oral, intravenous, and
opical pharmaceutical agents (Kulo et al., 2012; Fiume et al., 2012;
ealing et al., 2015).
Some studies have reported the ability of DMSO to act as a
ree radical scavenger, which gives it antioxidant properties. The
ntioxidant properties of DMSO limit its use as a solvent for
he development of new antioxidant drugs (Kabeya et al., 2013;
anmartín-Suárez et al., 2011; Bektasoglu et al., 2006).
Coumarins are low-molecular weight phenolic compounds and
ave various biological properties, including antioxidant activity.
n general, free radical scavenging and antioxidant activity of this
lass of compounds mainly depend on the number and position of
ydrogen-donating hydroxyl groups on the aromatic ring (Kostova
t al., 2011).
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Trolox 1.07 ± 0.04
Previous studies have reported the antioxidant potential of
paepalantine in the respiratory burst of neutrophils (Kitagawa et al.,
2003) and in the mitochondria (Devienne et al., 2007). In this study,
we evaluated the scavenging capacity of this compound against the
ABTS radical, reactive oxygen species such as O2•−, HOCl, and the
interference from solvents, DMSO and propylene glycol, in these
assays. The effect of solvents on ABTS•+ and O2•− assays is shown
in Fig. 4.
According to these data, DMSO and propylene glycol do not
interfere with these assays and the antioxidant effect of paepalan-
tine is unchanged, which is similar to Trolox (Fig. 5 and Table 1).
However, DMSO had an antioxidant effect against HOCl at all
concentrations tested. On the contrary, this phenomenon was  not
observed with propylene glycol, which shows interference only
at higher concentrations that were not employed in the test with
paepalantine (Fig. 6). Kabeya et al. (2013) observed the antioxidant
interference of DMSO in assays involving capture of HOCl. Stud-
ies suggest that the presence of the sulphur atom in the molecule
favours the oxidation of DMSO by HOCl (Peskin and Winterbourn,
2001; Ruff et al., 2012), directly inﬂuencing the results.
Paepalantine dissolved in propylene glycol showed higher
antioxidant activity in this assay, which seemed to be better than
Trolox (Fig. 7).
The results showed that paepalantine has signiﬁcant antiox-
idant activity against the reactive species studied, similar to
or better than that observed with Trolox. Further, paepalan-
tine possesses 9-OH and 10-OH groups providing a catechol-like
arrangement as well as a planar structure, both of which are highly
favourable to electron delocalization that is similar to the ortho-
diphenolic arrangement on the B-ring of ﬂavonoids, which is a
well-established requirement for the ROS-scavenging activities of
polyphenols (Pietta, 2000; Tejero et al., 2007; Devienne et al., 2007).
The results of the current study demonstrate that propyleneference in biological assays as antioxidant assays.
Additionally, previous studies showed that paepalantine is a
promising compound for pharmaceutical use; therefore this study
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